WHO

Switzerland’s drug authority, Swissmedic, has approved the first malaria medicine designed for newborns under five kilograms. Developed by Novartis, the…

An Israeli man has tragically passed away after contracting encephalitis caused by the rare Naegleria fowleri amoeba. This marks only…